Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gian D Pal

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Neuroscience|September 22, 2015
Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson diseaseGian D Pal, Maliha Shaikh, Christopher B Forsyth, et al.
Movement Disorders Clinical Practice|October 27, 2018
The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's DiseaseGian D Pal, Virginia Persinger, Bryan Bernard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2023
Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic VariantsGian D Pal, Daniel M Corcos, Leo Verhagen Metman, et al.
Operative Neurosurgery (Hagerstown, Md.)|January 11, 2021
Motor Evoked Potential Recordings During Segmented Deep Brain Stimulation-A Feasibility StudyJay Shils, Ryan B Kochanski, Alireza Borghei, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 22, 2022
Medication adversely impacts visually-guided eye movements in Parkinson's diseaseMiranda J Munoz, James L Reilly, Gian D Pal, et al.
Physiological Reports|August 29, 2024
Medication improves velocity, reaction time, and movement time but not amplitude or error during memory-guided reaching in Parkinson's diseaseMichael P Trevarrow, Miranda J Munoz, Yessenia M Rivera, et al.
Frontiers in Neurology|October 18, 2021
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot StudyFabian J David, Miranda J Munoz, Jay L Shils, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 17, 2021
Increased Subthalamic Nucleus Deep Brain Stimulation Amplitude Impairs Inhibitory Control of Eye Movements in Parkinson's DiseaseMiranda J Munoz, Lisa C Goelz, Gian D Pal, et al.
Frontiers in Human Neuroscience|October 18, 2023
Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson's diseaseMiranda J Munoz, Rishabh Arora, Yessenia M Rivera, et al.
Frontiers in Neurology|November 3, 2022
Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's diseaseFabian J David, Yessenia M Rivera, Tara K Entezar, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Neuroscience|September 22, 2015
Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson diseaseGian D Pal, Maliha Shaikh, Christopher B Forsyth, et al.
Movement Disorders Clinical Practice|October 27, 2018
The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's DiseaseGian D Pal, Virginia Persinger, Bryan Bernard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2023
Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic VariantsGian D Pal, Daniel M Corcos, Leo Verhagen Metman, et al.
Operative Neurosurgery (Hagerstown, Md.)|January 11, 2021
Motor Evoked Potential Recordings During Segmented Deep Brain Stimulation-A Feasibility StudyJay Shils, Ryan B Kochanski, Alireza Borghei, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 22, 2022
Medication adversely impacts visually-guided eye movements in Parkinson's diseaseMiranda J Munoz, James L Reilly, Gian D Pal, et al.
Physiological Reports|August 29, 2024
Medication improves velocity, reaction time, and movement time but not amplitude or error during memory-guided reaching in Parkinson's diseaseMichael P Trevarrow, Miranda J Munoz, Yessenia M Rivera, et al.
Frontiers in Neurology|October 18, 2021
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot StudyFabian J David, Miranda J Munoz, Jay L Shils, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 17, 2021
Increased Subthalamic Nucleus Deep Brain Stimulation Amplitude Impairs Inhibitory Control of Eye Movements in Parkinson's DiseaseMiranda J Munoz, Lisa C Goelz, Gian D Pal, et al.
Frontiers in Human Neuroscience|October 18, 2023
Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson's diseaseMiranda J Munoz, Rishabh Arora, Yessenia M Rivera, et al.
Frontiers in Neurology|November 3, 2022
Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's diseaseFabian J David, Yessenia M Rivera, Tara K Entezar, et al.
Pageof 2